Encyclopaedia - Finance

For the past fifteen years, I have served as a principal, a manager, a transactional advisor, a legal advisor and a financial advisor to privately held businesses and their owners. Over this time period,

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

I have noticed a lack of consistency in how Exit Strategy services are delivered to business owners. This inconsistency exists, even though succeeding a business is one of the most important and complex f

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

inancial decisions that will be made in that business owner’s lifetime. Proper planning and well timed exits can literally mean millions of dollars in additional Value and Wealth Preservation that is adde

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

to a business owner’s net worth and legacy.

Therefore, it is imperative to inform business owners and their advisors of recent developments in – and to provide timely information on – this increasingly i

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

mportant practice area. Few business owners or advisors today focus on developing multi-year ‘planned’ exits from a business. For millions of business owners who are looking to retire or move onto a new

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

phase of life, their exits often times lack the planning that may help ensure achieving that business owner’s personal goals.

Advisors to privately held businesses play a critical role in this Exit Strate

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ies process. Privately held businesses have limited resources. Sometimes there is a lack of capital because the seed money is mostly founder dollars, i.e. personal net worth. Sometimes resources are lim

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ited within labor or human resources, i.e. ‘management’, because small businesses have a hard time consistently recruiting and rewarding highly skilled and talented employees. As a result, the typical ent

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

repreneur fills many roles in the business and wears many hats. Often, most of that owner-operators’ time is allocated to ‘tactical’ items rather than ‘strategic’ objectives. This business owner relies o

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

advisors for ‘strategic’ planning. Development of an Exit Strategy is, by definition, a ‘strategic’ initiative that trusted advisors will initiate and design. Then, strong Teams of advisors will execute

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

that Exit Strategy for the business owner.

Today, there is a lack of focus on Exit Strategies. Although this type of planning is growing in importance, it does not fit perfectly within any one of the ‘t

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

raditional’ advisory roles, i.e. legal, accounting, financial, insurance, etc. . . . To fill this void, business owners and their advisors require Exit Strategy expertise in designing and executing Exit S

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

rategies, regardless of which discipline is initially presenting the idea. Exit Strategies planning includes a holistic and comprehensive review of the business owner’s corporate, personal, and family obj

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ectives. Generally speaking, the advisor who approaches the business owner as a ‘solutions provider’ instead of as a ‘product provider’ will likely spear-head this endeavor.

It’s imperative to continue t

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

o raise the awareness to the myriad options available to business owners for exiting their businesses. Business owners can consider ‘internal’ exits to employees, family, or co-owners as well as ‘external

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

or ‘third party’ exits to Private Equity Groups, Strategic Buyers, or through the Initial Public Offering (IPO) route. Each exit strategy takes a long time to execute because there is ‘no ready market’ f

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

or the transfer of privately held business interests. Further complicating this practice area is the fact that each privately held business is unique. Therefore, a description and/or valuation of each bu

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

siness requires time to assemble. Referencing my earlier comments about a ‘lack of resources’ amongst small businesses, I highlight the fact that it is often the business owners themselves who needs to co

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

pile the information required for these reports – in addition to continuing to operate their businesses. Exit Strategies are hard to design and even harder to execute. One of the best ways to overcome th

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e obstacles inherent in these deals is plain old persistence because a pro-active approach to an Exit Strategy is the only approach to a successful Exit Strategy.

Copywrite© 2007, Pinnacle Equity Solution

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.encyclopaedia.org.ua/article/101253/encyclopaedia-A-Proactive-Approach-To-An-Exit-Strategy-Is-The-Only-Approach-To-A-Successful-Exit-Strategy.html">A Proactive Approach To An Exit Strategy Is The Only Approach To A Successful Exit Strategy</a>

BB link (for phorums):
[url=http://www.encyclopaedia.org.ua/article/101253/encyclopaedia-A-Proactive-Approach-To-An-Exit-Strategy-Is-The-Only-Approach-To-A-Successful-Exit-Strategy.html]A Proactive Approach To An Exit Strategy Is The Only Approach To A Successful Exit Strategy[/url]

When hosting an online meeting it's important to consider your environment and prepare accordingly. Here are five tips for a successful meeting.

If you're anything like me you have been or are still trying to figure out the best ways to reach people on the Internet with your offers. I just wanted to clue you in to safelists and.......

Back links are healthy factor in the field of SEO to increase search engine rankings as well as increasig traffic for a website.

Tags

Links

Encyclopaedia - A Proactive Approach To An Exit Strategy Is The Only Approach To A Successful Exit Strategy

Related Articles: